Elvia Cowan - 16 Dec 2024 Form 4 Insider Report for Vaxcyte, Inc. (PCVX)

Role: SVP, FINANCE
Signature: Elvia Cowan, by /s/ Peter N. Efremenko, Attorney-In-Fact
Issuer symbol: PCVX
Transactions as of: 16 Dec 2024
Net transactions value: +$199,999
Form type: 4
Filing time: 18 Dec 2024, 16:13:19 UTC
Previous filing: 08 Nov 2024
Next filing: 03 Mar 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PCVX	Common Stock	Options Exercise	$199,999	+7,716	+67%	$25.92	19,294	16 Dec 2024	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PCVX	Stock Option (right to buy)	Options Exercise	$0	-7,716	-6.8%	$0.000000	106,284	16 Dec 2024	Common Stock	7,716	$25.92	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	1/4 of the shares subject to the option vested on July 1, 2023, and 1/48 of the shares vest monthly thereafter, subject to Reporting Person's continuous service with the Issuer through each such date.